Robert Dubiel

3.2k citations
22 papers · 1.5k indexed · 1 hit paper · h-index 12

Robert Dubiel

21 papers receiving 1.4k citations

Hit Papers

Idarucizumab for Dabigatran Reversal9812015202620182022250500750

Peers

Robert Dubiel
Comparison fields: 5 of 74
  • Internal Medicine 640
  • Cardiology and Cardiovascular Medicine 1.3k
  • Endocrinology, Diabetes and Metabolism 252
  • Nutrition and Dietetics 171
  • Neurology 132
Replace Paul A. Reilly with:
Paul A. Reilly United States
M Poggi Italy
Mark J. Antonino United States
Pål Smith Norway
Ingrid Copland Canada
Róbert Gábor Kiss Hungary
Chern‐En Chiang Taiwan
Steven V. Manoukian United States
Fabiana Rollini United States
Kirk E. Guyer United States
Robert Dubiel relative to Paul A. Reilly United States Paul A. Reilly's profile →
Citations per field
00.5×1.5×2.3×
Paul A. Reilly · 1×
Citations per year

Countries citing papers authored by Robert Dubiel

Since Specialization
Citations

This map shows the geographic impact of Robert Dubiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dubiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dubiel more than expected).

Fields of papers citing papers by Robert Dubiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dubiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dubiel. The network helps show where Robert Dubiel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert Dubiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Dubiel Line = papers co-authored together Robert Dubiel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20168
2
Initial results of the re-verse AD trial: idarucizumab reverses the anticoagulant effects of dabigatran in patients in an emergency setting of major bleeding, urgent surgery, or interventions
20152
3
Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study
20155
4 2015109
5
Idarucizumab for Dabigatran Reversalbreakdown →
2015981
6 20155
7 20125
8 20122
9 201113
10 20103
11 200932
12 200913
13 20094
14 200824
15 200728
16 200714
17 200740
18 200598
19 20051
20
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
200067

About Robert Dubiel

Robert Dubiel is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics and Surgery, having authored 22 papers that have together received 1.5k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (15 papers), Hormonal Regulation and Hypertension (10 papers), Sodium Intake and Health (7 papers), Atrial Fibrillation Management and Outcomes (6 papers), Acute Myocardial Infarction Research (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). The work is most often cited by research in Internal Medicine (640 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Endocrinology, Diabetes and Metabolism (252 citations), Nutrition and Dietetics (171 citations) and Neurology (132 citations). Robert Dubiel has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Jeffrey I. Weitz, Frank W. Sellke, Pieter W. Kamphuisen, Thorsten Steiner, Menno V. Huisman, Jerrold H. Levy, Joachim Stangier, CW Kam, Stephan Glund and Elaine M. Hylek. Their work appears in journals such as American Journal of Cardiovascular Drugs, Journal of Clinical Hypertension, Emergency Medicine Journal, Thrombosis and Haemostasis and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026